Cover Image

Pharmaceutical pricing and reimbursement policies: perspectives for the future

Saved in:

Bibliographic Details
Main Author:	Andrew L Gray (Author)
Format:	Book
Published:	Taylor & Francis Group, 2015-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmaceutical Pricing and Reimbursement Policies: lessons learnt and perspectives for Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
by: Sabine Vogler, et al.
Published: (2015)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
by: Elizabeth Docteur, et al.
Published: (2015)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
by: Dumebi O Mordi, et al.
Published: (2015)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
by: Bregtje W. Kamphuis, et al.
Published: (2021)

Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
by: Vivian Chen, et al.
Published: (2023)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Medicines pricing and reimbursement: innovation, competitiveness, and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, et al.
Published: (2010)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, MD, et al.
Published: (2010)

A framework for assessing the impact of pharmaceutical reimbursement policies on incentives to innovate
by: Elizabeth Docteur, et al.
Published: (2015)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017)

Italy - a study case of medicines pricing and reimbursement
by: Valdete A. MELO, et al.
Published: (2022)

Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
by: Agnes Vitry
Published: (2015)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
by: David Elvira, et al.
Published: (2023)

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
by: Juan Carlos Rejon-Parrilla, et al.
Published: (2023)

A comparative analysis of pricing and reimbursement systems between Italy and Bulgaria
by: Carmen Cannavale, et al.
Published: (2024)

Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge - The value of pricing and reimbursement policies
Published: (2019)

Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019)

Pharmaceutical pricing policy in Greece: towards a different path.
by: Kyriakos Souliotis, et al.
Published: (2016)

Drug pricing and reimbursement information management: processes and decision making in the global economy
by: Dimitrios Tsourougiannis
Published: (2017)

Reimbursement of combined antihypertensive medicenes in Ukraine: aspects of inclusion and external reference pricing
by: A. O. Gonchar, et al.
Published: (2022)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
by: Di Wu, et al.
Published: (2022)

The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

The Effects of Cost Containment and Price Policies on Pharmaceutical Expenditure in South Korea
by: Woohyeon Kim, et al.
Published: (2022)

Pharmaceutical regulation, pricing, coverage and policy reform in the United States of America
by: Mariana P. SOCAL, et al.
Published: (2022)

Systematic reviews of ten pharmaceutical pricing policies - a research protocol
by: David Tordrup, et al.
Published: (2020)

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
by: Afschin Gandjour
Published: (2020)

Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
by: David Elvira, et al.
Published: (2021)

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
by: SungKyung Lee, et al.
Published: (2023)

Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
by: Hans-Georg Eichler, et al.
Published: (2023)

A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
by: Khadidja Abdallah, et al.
Published: (2021)

The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
by: Féline E. V. Scheijmans, et al.
Published: (2022)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
by: Karolina Badora, et al.
Published: (2017)

The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
by: Tomas Tesar, et al.
Published: (2021)

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
by: Xia Mingge MPH, et al.
Published: (2023)